NY

Naveen Yalamanchi

Partner at RTW Investments

New York, New York

Overview 

Naveen Yalamanchi is a Partner at RTW Investments, LP in New York, with a background in portfolio management and alternative investments. Having co-founded Rocket Pharmaceuticals and held CFO positions in healthcare-focused companies, he has made significant investments in companies like Beta Bionics and Magnolia Medical Technologies. Yalamanchi's career highlights include co-founding Rocket Pharmaceuticals and serving as Chief Financial Officer in healthcare companies, alongside making notable investments in Beta Bionics and Magnolia Medical Technologies.

Work Experience 

  • Partner

    2015 - Current

    Portfolio manager at RTW - $6.5b AUM healthcare investment firm. www.RTWfunds.com

RTW Investments makes investments in forward-thinking healthcare companies.

  • Co-Founder and Director

    2015

    A clinical stage gene therapy company. Lead indications include: Danon Disease, Fanconi Anemia, Pyruvate Kinase Deficiency. (NASDAQ: RCKT) www.rocketpharma.com

Rocket Pharmaceuticals is a biotech company that develops a pipeline of genetic therapies for rare childhood disorders.

Raised $891,357,888.00 from RTW Investments, Frazier Healthcare Partners, Sahsen Ventures and Civilization Ventures.

  • Board Observer

    2019

  • Board Observer

    2018

Magnolia Medical Technologies is a device development company that focuses on improving the accuracy of diagnostic blood culture tests.

Raised $117,328,098.00 from SightLine Partners, Sectoral Asset Management, RTW Investments, Janus Henderson Investors, HealthQuest Capital and Evidity Health Capital.

  • Chief Financial Officer

    2020 - 2023

    Health Sciences Acquisitions Corporation 2 (NASDAQ: HSAQ) completed a business combination with Orchestra Biomed (NASDAQ:OBIO) in Jan 2023.

  • Chief Financial Officer

    2019 - 2019

    Health Sciences Acquisitions Corporation (NASDAQ: HSAC) merged with Immunovant Ltd on December 18, 2019. The combined entity is "Immunovant, Inc" (NASDAQ: IMVT).

  • Board Observer

    2017 - 2019

DermTech develops and commercializes qPCR assays for skin samples using adhesive tape biopsy methods.

Raised $259,860,639.00 from HLM Venture Partners, Tech Coast Angels and Western States Investment Group.

  • Healthcare Portfolio Manager

    2011 - 2014

    Managed the healthcare strategy for three funds (long/short mutual fund, market-neutral product, hedge fund) on the Calamos Arista platform -- subsidiary of Calamos Investments, a multi-billion asset management firm. covered all healthcare sub-sectors.

Calamos Investments is a global investment firm committed to excellence in investment management and client services.

  • Portfolio Manager

    2010 - 2011

    Healthcare investment firm (former Davidson Kempner team)

RTW Investments makes investments in forward-thinking healthcare companies.

  • Healthcare Analyst

    2009 - 2009

    Analyst at Millennium Partners. Covering healthcare, with special focus on medical devices, tools, diagnostics, services.

Articles About Naveen

Relevant Websites